Cwa Asset Management Group, LLC Astrazeneca PLC Transaction History

Cwa Asset Management Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$76.67 - $87.62 $261,598 - $298,959	3,412 New	3,412 $265,000
Q4 2022 Jan 09, 2023	BUY	$54.21 - $70.44 $184,639 - $239,918	3,406 New	3,406 $0
Q1 2022 Apr 21, 2022	SELL	$55.72 - $67.12 $30,646 - $36,916	-550 Reduced 13.98%	3,383 $224,000
Q4 2021 Feb 15, 2022	BUY	$54.02 - $63.83 $16,043 - $18,957	297 Added 8.17%	3,933 $229,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $2,944 - $3,221	53 Added 1.48%	3,636 $218,000
Q2 2021 Aug 03, 2021	BUY	$48.42 - $60.18 $173,488 - $215,624	3,583 New	3,583 $216,000
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $280,591 - $335,529	-5,783 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $21,228 - $24,440	400 Added 7.43%	5,783 $317,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $16,507 - $21,183	383 Added 7.66%	5,383 $285,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $188,950 - $256,650	-5,000 Reduced 50.0%	5,000 $223,000
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $372,800 - $416,800	10,000 New	10,000 $413,000

1,335

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwa Asset Management Group, LLC with notifications on news.